Fleming, Sheila M.
Northeast Ohio Medical University
4 papers on CoChatORCID 0000-0001-7090-8274
Most cited papers
- Verified
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
Goldberg, M. S., Fleming, S. M., Palacino, J. J., Cepeda, C., Lam, H. A., Bhatnagar, A., Meloni, E. G., Wu, N., Ackerson, L. C., Klapstein, G. J., et al. (2003) · Journal of Biological Chemistry
Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling
Cited by 913
- Verified
A Neurovascular Niche for Neurogenesis after Stroke
Ohab, J. J., Fleming, S., Blesch, A., & Carmichael, S. T. (2006) · The Journal of Neuroscience
Neurogenesis and neuroplasticity mechanismsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 878
- Verified
Defining α-synuclein species responsible for Parkinson’s disease phenotypes in mice
Froula, J. M., Castellana-Cruz, M., Anabtawi, N. M., Camino, J. D., Chen, S. W., Thrasher, D. R., Freire, J., Yazdi, A. A., Fleming, S., Dobson, C. M., et al. (2019) · Journal of Biological Chemistry
Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments
Cited by 129
- Verified
Pharmacological inhibition of CSF1R by GW2580 reduces microglial proliferation and is protective against neuroinflammation and dopaminergic neurodegeneration
Neal, M. L., Fleming, S. M., Budge, K. M., Boyle, A. M., Kim, C., Alam, G., Beier, E. E., Wu, L., & Richardson, J. R. (2020) · The FASEB Journal
Neuroinflammation and Neurodegeneration MechanismsParkinson's Disease Mechanisms and Treatments
Cited by 123
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free